» Articles » PMID: 33209020

FEF Values in Patients with Normal Lung Function Can Predict the Development of Chronic Obstructive Pulmonary Disease

Overview
Publisher Dove Medical Press
Specialty Pulmonary Medicine
Date 2020 Nov 19
PMID 33209020
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The forced mid-expiratory flow (FEF) value is a potentially sensitive marker of obstructive peripheral airflow. We aimed to assess whether FEF can be an early predictor of chronic obstructive pulmonary disease (COPD).

Patients And Methods: Between July 1, 2007 and June 31, 2009, we identified 3624 patients who underwent a pulmonary function test (PFT) in Gangnam Severance Hospital. We selected 307 patients aged over 40 years without COPD who had normal PFT results at baseline and who had follow-up PFT records more than 1 year later. A FEF z-score less than -0.8435 was considered low. We defined COPD as a forced expiratory volume in one second/forced vital capacity value of less than 0.7 before July 31, 2019.

Results: Among 307 patients, 91 (29.6%) had low FEF at baseline. After 10 years, the incidence rate of COPD in the low FEF group was significantly higher than that in the normal FEF group (41.8% vs 7.4%; <0.001). The Cox proportional hazard model showed that age (hazard ratio [HR] 1.09; -value<0.001), smoking status (occasional smoker HR, 4.59; -value<0.001 and long-term smoker HR, 2.18; -value=0.023), and low FEF (HR, 3.31; -value<0.001) were predictive factors for the development of COPD.

Conclusion: The FEF value in patients with normal lung function is a useful predictor for the development of COPD. We should carefully monitor patients who present with low FEF values, even if they have normal lung function.

Citing Articles

Physiological Small Airways Dysfunction and the Bronchodilator Response in Adults With Asthma and Its Risk Factors: A Retrospective Analysis.

Almeshari M, Alobaidi N, Stockley J, Stockley R, Nagakumar P, Sutton B J Asthma Allergy. 2025; 18:377-389.

PMID: 40066295 PMC: 11892509. DOI: 10.2147/JAA.S489893.


Optimal spirometry thresholds for the prediction of chronic airflow obstruction: a multinational longitudinal study.

Lam A, Alhajri S, Potts J, Harrabi I, Anand M, Janson C ERJ Open Res. 2025; 11(2).

PMID: 40040898 PMC: 11873882. DOI: 10.1183/23120541.00624-2024.


Diagnostic value of lung function tests in long COVID: analysis of positive bronchial provocation test outcomes.

Liu W, Feng Q, Yuan X, Lu C, Wang S, Yuan Y Front Med (Lausanne). 2025; 11():1512658.

PMID: 39830383 PMC: 11738905. DOI: 10.3389/fmed.2024.1512658.


Septoplasty-mediated improvements in nasal patency and pulmonary function: A prospective study.

Sousa F, Correia J, Carvalho Almeida J, Raquel Azevedo S, Ferreira M, Magalhaes M Laryngoscope Investig Otolaryngol. 2025; 10(1):e70065.

PMID: 39780865 PMC: 11705537. DOI: 10.1002/lio2.70065.


Assessing the short-term hematological and pulmonary effects of air pollution: a cross-sectional study in a Turkish urban setting.

Kilincer M, Gursoy E BMC Public Health. 2025; 25(1):16.

PMID: 39748373 PMC: 11697805. DOI: 10.1186/s12889-024-21246-6.


References
1.
Csikesz N, Gartman E . New developments in the assessment of COPD: early diagnosis is key. Int J Chron Obstruct Pulmon Dis. 2014; 9:277-86. PMC: 3942111. DOI: 10.2147/COPD.S46198. View

2.
Patterson G, Wilson S, Whang J, Harvey J, Agacki K, Patel H . Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second. J Heart Lung Transplant. 1996; 15(2):175-81. View

3.
Youden W . Index for rating diagnostic tests. Cancer. 1950; 3(1):32-5. DOI: 10.1002/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3. View

4.
Niewoehner D, KLEINERMAN J, Rice D . Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med. 1974; 291(15):755-8. DOI: 10.1056/NEJM197410102911503. View

5.
Welte T, Vogelmeier C, Papi A . COPD: early diagnosis and treatment to slow disease progression. Int J Clin Pract. 2014; 69(3):336-49. DOI: 10.1111/ijcp.12522. View